Silver Spring, Maryland–(ENEWSPF)–May 16, 2013. The U.S. Food and Drug Administration yesterday approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.
FDA Approves Simponi to Treat Ulcerative Colitis
More in Health and Fitness:
